The global breast cancer screening tests market is poised for significant growth in the coming years. In 2024, the market is expected to be valued at USD 4.44 billion and is projected to grow to USD 4.75 billion by 2025, with an estimated market size of USD 8.77 billion by 2034. The market is expected to expand at a CAGR of 7.04% between 2025 and 2034, driven by increasing demand, awareness, and government initiatives supporting early detection of breast cancer. With technological advancements like MRI, ultrasound, and 3D mammography enhancing diagnostic accuracy, North America is expected to dominate the market. Meanwhile, Asia Pacific is anticipated to be the fastest-growing region due to rising breast cancer cases and improving healthcare infrastructure.
Key Insights into the Breast Cancer Screening Tests Market
-
Market Size and Growth: The market size was valued at USD 4.44 billion in 2024, projected to reach USD 4.75 billion by 2025 and USD 8.77 billion by 2034, growing at a CAGR of 7.04% from 2025 to 2034.
-
Dominant Regions: North America is expected to dominate the breast cancer screening tests market in 2024. The fastest growth will come from the Asia Pacific region between 2025 and 2034.
-
Test Types: The imaging tests segment is the largest revenue generator in 2024, while the blood marker tests segment is expected to be the fastest-growing over the forecast period.
-
Sample Types: The tissue biopsy segment will dominate the market in 2024. However, the blood segment is projected to experience the fastest growth from 2025 to 2035.
Leading Companies in the Breast Cancer Screening Tests Market
The breast cancer screening tests market comprises several prominent players, each contributing significantly to the market’s growth and innovation. Below are some of the leading companies that are shaping the future of the industry.
1. Hologic Inc.
About: Hologic is a global medical technology company that focuses on improving women’s health. Known for its innovations in breast cancer diagnostics, the company has a strong presence in the breast cancer screening market.
Products: Hologic offers a range of breast cancer screening technologies, including digital mammography, 3D mammography (breast tomosynthesis), and other diagnostic tools aimed at improving early detection.
Market Cap: Hologic’s market cap is approximately USD 19.48 billion as of 2024.
2. Siemens Healthineers
About: Siemens Healthineers is a leading global healthcare technology company that specializes in medical imaging, laboratory diagnostics, and healthcare IT. The company is a key player in the breast cancer screening market, offering cutting-edge imaging solutions.
Products: Siemens Healthineers offers advanced imaging systems for mammography, including digital mammography and MRI systems, to enhance breast cancer detection.
Market Cap: Siemens Healthineers has a market capitalization of approximately USD 70 billion as of 2024.
3. GE Healthcare
About: GE Healthcare is a leading global medical technology and life sciences company. It provides a wide range of medical devices and technologies for breast cancer screening and diagnostic imaging.
Products: GE Healthcare’s portfolio includes digital mammography systems, ultrasound imaging solutions, and MRI machines for accurate breast cancer detection.
Market Cap: GE Healthcare’s parent company, General Electric, has a market cap of about USD 123 billion.
4. Philips Healthcare
About: Philips Healthcare is a subsidiary of Royal Philips, a global leader in health technology. The company is known for its innovative diagnostic imaging systems and breast cancer screening technologies.
Products: Philips offers advanced mammography systems, including digital and 3D mammography devices that improve early breast cancer detection.
Market Cap: Royal Philips has a market cap of around USD 45 billion.
5. Canon Medical Systems
About: Canon Medical Systems is a leading medical imaging company that offers advanced diagnostic imaging technologies for various applications, including breast cancer screening.
Products: Canon provides a range of imaging solutions, such as mammography machines, CT scanners, and ultrasound systems, for early detection and monitoring of breast cancer.
Market Cap: Canon Medical is a subsidiary of Canon Inc., which has a market cap of approximately USD 25 billion.
6. Fujifilm Holdings Corporation
About: Fujifilm is a diversified global company known for its contributions to healthcare, including diagnostic imaging and breast cancer screening solutions.
Products: Fujifilm offers a comprehensive range of imaging systems, including digital mammography and ultrasound solutions for breast cancer detection.
Market Cap: Fujifilm’s market capitalization is about USD 21 billion.
7. Hitachi Medical Corporation
About: Hitachi Medical Corporation is part of the Hitachi Group and is a global leader in medical equipment, particularly in diagnostic imaging.
Products: Hitachi offers advanced imaging technologies for breast cancer screening, including MRI and ultrasound systems.
Market Cap: Hitachi’s market cap is approximately USD 53 billion.
8. Toshiba Medical Systems Corporation
About: Toshiba Medical Systems, now known as Canon Medical, is a leading provider of diagnostic imaging technologies for various medical conditions, including breast cancer.
Products: The company provides imaging systems such as MRI, CT, and ultrasound for early breast cancer detection.
Market Cap: Toshiba’s parent company, Toshiba Corporation, has a market cap of around USD 13 billion.
9. Samsung Medison Co., Ltd.
About: Samsung Medison is a leading provider of ultrasound imaging systems and a key player in the breast cancer screening market.
Products: Samsung Medison offers advanced ultrasound devices used for early detection and diagnosis of breast cancer.
Market Cap: Samsung Medison is a subsidiary of Samsung Electronics, which has a market capitalization of around USD 370 billion.
10. Mindray Medical International Limited
About: Mindray is a global leader in medical devices and solutions. The company is committed to improving healthcare through innovative diagnostic tools, including breast cancer screening solutions.
Products: Mindray offers ultrasound and other diagnostic imaging systems for breast cancer detection.
Market Cap: Mindray’s market capitalization is approximately USD 20 billion.
11. Varian Medical Systems
About: Varian Medical Systems, now part of Siemens Healthineers, is a leader in the field of medical imaging and radiation therapy.
Products: Varian’s offerings include diagnostic imaging systems, radiation therapy equipment, and oncology treatment solutions for breast cancer.
Market Cap: Varian’s market cap was approximately USD 17 billion at the time of acquisition by Siemens.
12. Exact Sciences Corporation
About: Exact Sciences is a molecular diagnostics company known for its innovations in cancer detection, including breast cancer.
Products: Exact Sciences offers tests that detect breast cancer and other cancers through blood-based biomarkers.
Market Cap: Exact Sciences’ market capitalization is approximately USD 11 billion.
13. Guardant Health
About: Guardant Health is a leader in liquid biopsy technology, focused on developing non-invasive cancer detection methods.
Products: Guardant offers blood-based biomarker tests for early cancer detection, including breast cancer.
Market Cap: Guardant Health has a market cap of around USD 16 billion.
14. Natera Inc.
About: Natera is a leader in genetic testing, providing diagnostics for various types of cancer, including breast cancer.
Products: Natera’s offerings include genetic tests and blood-based screening tools for breast cancer detection.
Market Cap: Natera’s market capitalization is approximately USD 7 billion.
15. Biocept Inc.
About: Biocept is a molecular diagnostics company that specializes in liquid biopsy and cancer screening.
Products: Biocept offers blood-based tests for early breast cancer detection, using advanced biomarker technologies.
Market Cap: Biocept’s market capitalization is approximately USD 50 million.
16. Roche Diagnostics
About: Roche Diagnostics is a division of Roche, one of the world’s largest healthcare companies, specializing in diagnostic solutions.
Products: Roche offers a wide range of diagnostic tools, including blood-based biomarkers for breast cancer detection.
Market Cap: Roche’s market capitalization is approximately USD 230 billion.
17. Abbott Laboratories
About: Abbott Laboratories is a global healthcare company that develops medical devices, diagnostics, and nutritional products.
Products: Abbott’s offerings include blood-based tests and diagnostic imaging systems for breast cancer screening.
Market Cap: Abbott Laboratories has a market capitalization of approximately USD 230 billion.
If you have any questions, please feel free to contact us at sales@towardshealthcare.com
FAQs on Breast Cancer Screening Tests Market
1. What is the projected growth rate of the breast cancer screening tests market?
The market is expected to grow at a CAGR of 7.04% from 2025 to 2034.
2. Which region is dominating the breast cancer screening tests market?
North America is expected to dominate the market due to technological advancements in imaging tests.
3. What are the fastest-growing segments in the breast cancer screening market?
The blood marker tests segment and the blood sample type segment are expected to grow the fastest.
4. What are the key players in the breast cancer screening tests market?
Key players include Hologic Inc., Siemens Healthineers, GE Healthcare, Philips Healthcare, and many others.
5. What technological advancements are driving the growth of this market?
Technologies like 3D mammography, MRI, ultrasound, and blood marker tests are significantly enhancing diagnostic accuracy, driving the market growth.
Source : https://www.towardshealthcare.com/insights/breast-cancer-screening-tests-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5847